Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 2009

View Archived Issues

Tafluprost exhibits similar efficacy to latanoprost in phase II and III trials

Vitreosolve effective in clinical trials for PVD induction in diabetic retinopathy

Endoscopic trial in healthy subjects supports favorable efficacy of LT-NS001

FDA approves use of Diamyd vaccine in young children in TrialNet GAD diabetes study

Phase III program of TAK-085 in hypertriglyceridemia initiated in Japan

MRC reports results from international trial of PRO-2000 preventative HIV gel

Emend approved in Japan for chemotherapy-induced nausea and vomiting

ChemGenex and Hospira agree to codevelop omacetaxine for CML

ProMetic Life Sciences meets with FDA on regulatory pathway of PBI-1402

FDA approves Eli Lilly's Zyprexa Relprevv for schizophrenia in adults

Opexa Therapeutics reports securities offering to develop its MS therapy

Alcon to acquire Optonol

Data from phase II and III trials support efficacy of prucalopride in chronic constipation

GMI-1070 shows safety and tolerability in phase I trial in healthy subjects

Phase I data reported for terameprocol in patients with advanced leukemias

CALISTO trial reveals efficacy of fondaparinux in treating superficial vein thrombosis

Roche's ocrelizumab meets primary endpoint in phase III rheumatoid arthritis trial

TGen to test Nerviano Medical Sciences' new anticancer drug NMS-1286937

Pfizer presents FAAH inhibitors for the treatment of pain and other conditions

Vasopressin V1a receptor antagonists identified by sanofi-aventis

Takeda describes ASK1 inhibitors

Vertex describes PI3Kgamma kinase inhibitors for multiple sclerosis therapy

Novel ALK and Bcr-Abl inhibitors claimed by European scientists for cancer therapy

Kowa Pharmaceuticals divests diclofenac products Cambia and PRO-571

Qiagen closes acquisition of SABiosciences

BioAlliance's acyclovir Lauriad achieves endpoints in phase III trial

Ambit Biosciences initiates phase II trial of AC-220 in acute myeloid leukemia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...